pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer

References

• Izrailit J, Reedijk M. Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications. Cancer Lett. 2012;317:115–126.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Alakhova DY, Kabanov AV. Can nanomedicines kill cancer stem cells? Adv Drug Deliv Rev. 2013a;65:1763–1783.
   PubMed Web of Science ®Google Scholar
• Meng F, Zhong Y, Cheng R, et al. pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances. Nanomedicine (Lond). 2014;9:487–499.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wei X, Zhang C, et al. Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects. Ther Deliv. 2010;1:273–287.
   PubMedGoogle Scholar
• Xu H, Yao Q, Cai C, et al. Amphiphilic poly(amino acid) based micelles applied to drug delivery: the in vitro and in vivo challenges and the corresponding potential strategies. J Control Release. 2015c;199:84–97.
   PubMed Web of Science ®Google Scholar
• El-Rayes BF, Ibrahim D, Shields AF, et al. Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors. Invest New Drugs. 2005;23:57–62.
   PubMed Web of Science ®Google Scholar
• Alakhova DY, Zhao Y, Li S, et al. Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia. PLoS One. 2013;8:e72238.,
   PubMed Web of Science ®Google Scholar
• Matsumura Y. [Micelle carrier system in clinical trial]. Nihon Rinsho. 2006;64:316–321.
   PubMedGoogle Scholar
• Xu HL, Fan ZL, ZhuGe DL, et al. Therapeutic supermolecular micelles of vitamin E succinate-grafted epsilon-polylysine as potential carriers for curcumin: Enhancing tumour penetration and improving therapeutic effect on glioma. Colloids Surf B Biointerfaces. 2017;158:295–307.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Hannafon BN, Ding WQ. Disulfiram's Anticancer Activity: Evidence and Mechanisms. Anticancer Agents Med Chem. 2016;16:1378–1384.
   PubMed Web of Science ®Google Scholar
• Liu P, Wang Z, Brown S, et al. Liposome encapsulated Disulfiram inhibits NFkappaB pathway and targets breast cancer stem cells in vitro and in vivo. Oncotarget. 2014;5:7471–7485.
   PubMed Web of Science ®Google Scholar
• Yang Z, Sun N, Cheng R, et al. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells. Biomaterials. 2017;147:53–67.
   PubMed Web of Science ®Google Scholar
• Han D, Wu G, Chang C, et al. Disulfiram inhibits TGF-beta-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-kappaB/Snail pathway. Oncotarget. 2015;6:40907–40919.
   PubMedGoogle Scholar
• Wang Z, Tan J, McConville C, et al. Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells. Nanomedicine. 2017;13:641–657.
   PubMed Web of Science ®Google Scholar
• Zhu JY, Yang X, Chen Y, et al. Curcumin suppresses lung cancer stem cells via inhibiting Wnt/beta-catenin and sonic Hedgehog pathways. Phytother Res. 2017;31:680–688.
   PubMed Web of Science ®Google Scholar
• Zhang L, Tian B, Li Y, et al. A copper-mediated disulfiram-loaded pH-triggered PEG-shedding TAT peptide-modified lipid nanocapsules for use in tumor therapy. Acs Appl Mater Inter. 2015;7:25147–25161.
   PubMed Web of Science ®Google Scholar
• Jing G, Zhong Y, Zhang L, et al. Increased dissolution of disulfiram by dry milling with silica nanoparticles. Drug Dev Ind Pharm. 2015;41:1328–1337.
   PubMed Web of Science ®Google Scholar
• Xu H, Cai C, Gou J, et al. Self-assembled monomethoxy (polyethylene glycol)-b-P(D,L-lactic-co-glycolic acid)-b-P(L-glutamic acid) hybrid-core nanoparticles for intracellular pH-triggered release of doxorubicin. J Biomed Nanotechnol. 2015a;11:1354–1369.
   PubMed Web of Science ®Google Scholar
• Xu H, Yang D, Cai C, et al. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation. Acta Biomater. 2015b;16:156–168.
   PubMed Web of Science ®Google Scholar
• Xu HL, Mao KL, Lu CT, et al. An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma. Biomaterials. 2016;107:44–60.
   PubMed Web of Science ®Google Scholar
• Adahoun MA, Al-Akhras MH, Jaafar MS, et al. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artif Cells Nanomed Biotechnol. 2017;45:98–107.
   PubMed Web of Science ®Google Scholar
• Farajzadeh R, Pilehvar-Soltanahmadi Y, Dadashpour M, et al. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells. Artif Cells Nanomed Biotechnol. 2017. [Epub ahead of print]. DOI: https://doi.org/10.1080/21691401.2017.1347879
   PubMed Web of Science ®Google Scholar
• Liang H, Friedman JM, Nacharaju P. Fabrication of biodegradable PEG-PLA nanospheres for solubility, stabilization, and delivery of curcumin. Artif Cells Nanomed Biotechnol. 2017;45:297–304.
   PubMed Web of Science ®Google Scholar
• Wang JL, Sun J, Chen Q, et al. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Biomaterials. 2012;33:6877–6888.
   PubMed Web of Science ®Google Scholar
• Xu HL, Fang GH, Gou JX, et al. Lyophilization of self-assembled polymeric nanoparticles without compromising their microstructure and their in vivo evaluation: pharmacokinetics, tissue distribution and toxicity. J Biomater Tiss Eng. 2015d;5:919–929.
   Web of Science ®Google Scholar
• Han K, Zhang WY, Zhang J, et al. pH-responsive nanoscale coordination polymer for efficient drug delivery and real-time release monitoring. Adv Healthc Mater. 2017;6:1700471-1700479.
   Web of Science ®Google Scholar
• Zhao Y, Alakhova DY, Kim JO, et al. A simple way to enhance Doxil (R) therapy: Drug release from liposomes at the tumor site by amphiphilic block copolymer. J Controlled Release. 2013b;168:61–69.
   PubMed Web of Science ®Google Scholar
• Mirakabad FST, Akbarzadeh A, Milani M, et al. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol. 2016;44:423–430.
   PubMed Web of Science ®Google Scholar
• Kang XJ, Wang HY, Peng HG, et al. Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy. Acta Pharmacol Sin. 2017;38:885–896.
   PubMed Web of Science ®Google Scholar
• Wang N, He T, Shen YM, et al. Paclitaxel and tacrolimus coencapsulated polymeric micelles that enhance the therapeutic effect of drug-resistant ovarian cancer. Acs Appl Mater Inter. 2016; 8:4368–4377.
   PubMed Web of Science ®Google Scholar
• Hong W, Chen D, Zhang X, et al. Reversing multidrug resistance by intracellular delivery of Pluronic(R) P85 unimers. Biomaterials. 2013;34:9602–9614.
   PubMed Web of Science ®Google Scholar
• Nasab NA, Kumleh HH, Beygzadeh M, et al. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Artif Cells Nanomed Biotechnol. 2017. [Epub ahead of print]. DOI: https://doi.org/10.1080/21691401.2017.1290648
   Google Scholar
• Burke AR, Singh RN, Carroll DL, et al. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials. 2012;33:2961–2970.
   PubMed Web of Science ®Google Scholar
• Wang D, Huang JB, Wang XX, et al. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel. Biomaterials. 2013;34:7662–7673.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang H, Wang XQ, et al. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials. 2012;33:679–691.
   PubMed Web of Science ®Google Scholar
• Duan X, Xiao J, Yin Q, et al. Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano. 2013;7:5858–5869.
   PubMed Web of Science ®Google Scholar
• Hirsch HA, Iliopoulos D, Struhl K. Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. Proc Natl Acad Sci USA. 2013; 110:972–977.
   PubMed Web of Science ®Google Scholar
• Ke XY, Lin Ng VW, Gao SJ, et al. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials. 2014;35:1096–1108.
   PubMed Web of Science ®Google Scholar
• Haynes B, Sarma A, Nangia-Makker P, et al. Breast cancer complexity: implications of intratumoral heterogeneity in clinical management. Cancer Metastasis Rev. 2017;36:547-555.
   PubMed Web of Science ®Google Scholar
• Toss M, Miligy I, Thompson AM, et al. Current trials to reduce surgical intervention in ductal carcinoma in situ of the breast: critical review. Breast. 2017;35:151–156.
   PubMed Web of Science ®Google Scholar